Walleye Capital
BBNX

Walleye Capital’s Beta Bionics BBNX Stock Holding History

Walleye Capital’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-646,539
Closed -$19.7M – 5110
2025
Q4 		$19.7M Buy
646,539
+55,352
+9% +$1.48M 0.06% 306
2025
Q3 		$11.7M Buy
591,187
+372,998
+171% +$6.55M 0.04% 468
2025
Q2 		$3.18M Buy
218,189
+70,084
+47% +$992K 0.01% 1164
2025
Q1 		$1.81M Buy
+148,105
New +$2.76M 0.01% 1493

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Walleye Capital's BBNX Position: Q1 2026 in Review

Walleye Capital sold out of Beta Bionics (BBNX) in Q1 2026, closing a stake of 646,539 shares — an estimated $19.7M sold.

Walleye Capital first reported a position in BBNX in Q1 2025 and held it in 4 quarters. The position peaked at $19.7M in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Walleye Capital reported no remaining Beta Bionics position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 646,539 Beta Bionics shares in Q1 2026, an estimated $19.7M.
  • Walleye Capital first reported a position in Beta Bionics in Q1 2025 and held it in 4 quarters.
  • Walleye Capital's Beta Bionics position peaked at $19.7M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.